Browse ACC's Educational Products

  Patient Case Quizzes
  Certified Patient Cases
  Certified Patient Cases

Imaging Case Series: Coronary CT Angiography in CAD
July 20, 2017 | CME 0.25 MOC 0.25 COP 0.25

This activity was created with a goal to change your competence in managing patients with suspected coronary artery disease using coronary computed tomography angiography.

CardioMEMS HF System for Reduction in HF Hospitalization
July 10, 2017 | CME 0.25 MOC 0.25 COP 0.25

This activity was planned with a goal to familiarize learners with the Food and Drug Administration approved CardioMEMS HF System (May 2014) as an option to decrease HF hospitalizations in select patients.

Congenital Heart Disease and New or Progressive HF in Pregnancy
June 30, 2017 | CME 0.25 MOC 0.25 COP 0.25

This activity was planned with a goal to improve your competence in evaluating and treating adults with congenital heart disease and new or progressive heart failure.

Imaging Case Series: Left Main Disease (Nuclear)
June 28, 2017 | CME 0.25 MOC 0.25 COP 0.25

This activity was planned with a goal to change your competence in recognizing left main disease on SPECT myocardial perfusion imaging. This case is part of the Imaging Case Series.

Professionalism Case Series: Raising Concerns Without Fear of Intimidation
June 20, 2017 | CME 0.25 MOC 0.25 COP 0.25

This activity was planned with a goal to change provider behavior and professionalism. This case is part of the Professionalism Case Series and intended for cardiovascular physicians, adult physicians, pediatric physicians, and surgeons.

Guideline Education: Medical Therapy and ICD Placement in Patients with HFrEF
June 14, 2017 | CE 0.25 CME 0.25 MOC 0.25 COP 0.25

This activity was planned with a goal to improve your competence in managing patients with HFrEF and your clinical decision making involving guideline-directed medical therapy and ICD placement. This activity was created in response to the 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death.

MORE

Guideline Education: Assessment and Management of Chronic Peripheral Arterial Disease
June 7, 2017 | CE 0.25 CME 0.25 MOC 0.25 COP 0.25

The overall goal of this CME certified, online activity is to classify and manage different stages of chronic peripheral vascular disease according to the latest guidelines. This content was created in response to the 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease.

Periprocedural Interruption and Bridging of Anticoagulation: Nonvalvular AF
May 30, 2017 | CE 0.25 CME 0.25 MOC 0.25 COP 0.25

The overall goal of this CME certified, online activity is to to promote enhanced competence in the interruption and bridging of periprocedural anticoagulation in patients with nonvalvular atrial fibrillation. This activity was created in response to the 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation.

ACHD Case Series: Endocardial Cushion Defect
May 23, 2017 | CME 0.25 MOC 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in identifying, diagnosing, and treating patients with sinus venosus defects.

Patient Presents with Cardiac Arrest and is Considered for an Implantable Cardioverter-Defibrillator
May 16, 2017 | CE 0.25 CME 0.25 MOC 0.25

The overall goal of this CME certified, online activity is to change your competence in managing anticoagulation in patients with nonvalvular atrial fibrillation. This activity was created in response to the 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death.

Imaging Case Series: Vascular Territories on SPECT Imaging (Nuclear)
May 08, 2017 | CME 0.25 MOC 0.25

The overall goal of this CME certified, online activity is to improve your ability to identify/define vascular territories on SPECT imaging to help guide management decisions.

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
May 02, 2017 | CME 0.25 MOC 0.25

The overall goal of this CME certified, online activity is to change competence in periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation.

MORE

ACHD Case Series: Sinus Venosus Defect
Apr 24, 2017 | CNE 0.25 CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in identifying, diagnosing, and treating patients with sinus venosus defects.

Imaging Case Series: Conduction System Abnormalities (Nuclear)
Apr 17, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to be able to identify indications of nuclear stress testing, and recognize the patterns of artifacts caused by pacing and bundle branch blocks.

Pre-TAVR Testing: Patient Presents with Dyspnea on Exertion
Apr 10, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in choosing the optimal pre-TAVR testing schema and imaging modalities. This case was created in response to 2016 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults with Aortic Stenosis.

Asymptomatic Patient Presents with Family History of SCD
Apr 04, 2017 | CE 0.25 CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying the at-risk population for SCD, and choosing the appropriate screening test these patients. This content was created in response to the 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death.

ACHD Case Series: Atrial Septal Defect
Mar 27, 2017 | CE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to improve your ability to identify, diagnose, and treat patients who have an ASD.

MORE

Imaging Case Series: Lung/Heart Ratio in Nuclear Cardiology (Nuclear)
Mar 21, 2017 | CME 0.25

The overall goal of this CME certified, online activity is to augment the learner’s understanding of the use of the lung/heart ratio in nuclear cardiology.

Guideline Education: Medical Therapy for the PAD Patient
Mar 06, 2017 | CE 0.50 CME 0.50 COP 0.50

The overall goal of this CME certified, online activity is to change your competence in treating patients with PAD. This content was created in response to the 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease.

Positional Ventricular Tachycardia
Feb 27, 2017 | CE 0.50 CME 0.50 COP 0.50

The overall goal of this CME certified, online activity is to improve your competence in recognizing and troubleshooting VT in typical clinical practice.

ACHD Case Series: Hypertrophic Cardiomyopathy
Feb 22, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with HCM.

Guideline Education: Peripheral Artery Disease and Chronic Limb Ischemia
Feb 16, 2017 | CE 0.50 CME 0.50 COP 0.50

The overall goal of this CME certified, online activity is to identify gaps in knowledge and strengthen confidence in management of critical limb ischemia. This content was created in response to the 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease.

MORE

Imaging Case Series: Transient Ischemic Dilation (Nuclear)
Feb 13, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your knowledge base for TID detected on nuclear stress tests.

ACHD Case Series: Anomalous Origin of Left Main Coronary Artery
Jan 31, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with anomalous origin of the left main coronary artery.

Intermediate Risk Patients with Severe Aortic Stenosis
Jan 23, 2017 | CE 0.50 CME 0.50 COP 0.50

The overall goal of this CME certified, online activity is to advance one’s knowledge of treatment options in intermediate-risk patients with severe aortic stenosis, and to improve one’s competency when treating patients with severe aortic stenosis.

Mitral Valve Prolapse: Patient Presents with a Systolic Murmur and Palpitations
Jan 09, 2017 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in the diagnosis and treatment of patients with mitral valve prolapse.

Anticoagulation in Patients with Atrial Fibrillation: Inpatient Clinical Practice
Jan 03, 2017 | CE 0.25 CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in managing anticoagulation in patients with nonvalvular atrial fibrillation.

MORE

Patients with Atrial Fibrillation: Outpatient Clinical Practice
Dec 19, 2016 | CE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence and outpatient clinical practice of patients with atrial fibrillation.

ACHD Case Series: Ebstein Anomaly
Dec 16, 2016 | CME 0.25 CNE 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with Ebstein anomaly.

Moderate Ischemic Mitral Regurgitation After a Myocardial Infarction
Dec 07, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to update your competence in identifying the effects of adding MV repair for moderate ischemic MR to patients undergoing CABG, particularly regarding long-term survival, LV remodeling, and heart failure symptoms.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia
Dec 05, 2016 | CE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence in applying recommended strategies to identify children and adolescents with FH.

ACHD Case Series: Isolated Left Ventricular Noncompaction
Nov 29, 2016 | CE 0.25 CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with isolated left ventricular noncompaction.

MORE

Heart Failure with Congenital Heart Disease and A Fontan Palliation
Nov 22, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in evaluating patients with complex CHD who develop chronic HF (CHF).

Guideline Education: A Patient With Stable Angina Undergoes PCI
Nov 07, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. Specifically, this exercise shall...

Management and Prevelance of Statin Intolerance
Nov 03, 2016 | CNE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to increase your comprehension of the GAUSS-3 trial.

ACHD Case Series: Scimitar Syndrome
Oct 27, 2016 | CNE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with scimitar syndrome.

Early Repolarization Pattern on Electrocardiogram
Oct 19, 2016 | CNE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to enable the learner to define early repolarization pattern, describe its prevalence, and be familiar with its clinical implications, as summarized in the American Heart Association Scientific Statement on Electrocardiographic Early Repolarization.

MORE

Stroke Prevention in Patients with Nonvalvular AF and CAD
Oct 17, 2016 | CE 0.5 CME 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence in oral anticoagulation treatment for stroke prevention in individual patients with nonvalvular atrial fibrillation.

Guideline Education: Dual Antiplatelet Therapy in Patients with CAD
Oct 12, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in using DAPT in treating patients with coronary artery disease based on the 2016 American College of Cardiology/American Heart Association (ACC/AHA) Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease.

Management of Atrial Fibrillation After Cardiac Surgery
Sep 26, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to update your clinical knowledge and competence regarding management of patients with AF after cardiac surgery.

ACHD Case Series: Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)
Sep 16, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with ARVC/D.

Aortic Stenosis and Aortic Valve Disease
Sep 13, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to expand your competence in treating patients with aortic valve disease. This case is based on the ACC.16 Clinical Focus Session: Valve Therapy in Tomorrowland.

Evaluation and Management of Severe Mitral Regurgitation
Sep 06, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to expand your competence in treating patients with mitral valve disease. This case is based on the ACC.16 Clinical Focus Session: Valve Therapy in Tomorrowland.

MORE

Guideline Education: Composition and Duration of DAPT with Anticoagulation
Sep 02, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the American College of Cardiology/American Heart Association Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease. Specifically, this activity will improve competence and performance in combining dual antiplatelet therapy with anticoagulation.

Patient Presents with Shortness of Breath, Palpitations, and Bilateral Lower-extremity Edema for 2 Days
Aug 29, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in treating patients with HF and hyperkalemia. This case is based on the ACC.16 Clinical Focus Session: The Nuts and Bolts of Heart Failure Therapies: Pharmacological Case Challenges.

ACHD Case Series: Transposition of the Great Arteries
Aug 25, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with transposition of the great arteries (TGA).

34-Year-Old Male Presents with Complex Congenital Heart Disease and Worsening Dyspnea
Aug 23, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in evaluating and treating adults with congenital heart disease and new or progressive heart failure.

Patient with HFrEF Presents with Lightheadedness, Blurry Vision, and Hypotension
Aug 23, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in treating patients with heart failure with reduced ejection fraction. This case is based on the ACC.16 Clinical Focus Session: The Nuts and Bolts of Heart Failure Therapies: Pharmacological Case Challenges.

MORE

Premature Coronary Artery Disease and Hyperlipidemia
Aug 16, 2016 | CME 0.5 CE 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence in managing nonstatin therapy for low-density lipoprotein lowering in patients at high atherosclerotic cardiovascular disease risk.

ACHD Case Series: Diagnosis and Treatment of Patients with Coarctation of the Aorta
Jul 21, 2016 | CME 0.5 CE 0.5 COP 0.5

The overall goal of this CME certified, online activity is to change your competence in identifying, diagnosing, and treating patients with coarctation of the aorta.

Medical Therapy in Patients with HFrEF
Jul 21, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in managing patients with heart failure with reduced ejection fraction, and improve clinical decision making using guideline-directed medical therapy, including ivabradine. This activity is based on the 2016 ACC.16 Heart Failure Clinical Focus Session and the 2016 American College of Cardiology/American Heart Association/Heart Failure Society of America Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. This case is based on the ACC.16 Clinical Focus Session: The Nuts and Bolts of Heart Failure Therapies: Pharmacological Case Challenges.

Clinical Decision Making in Patients with HFrEF
Jul 20, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in managing patients with heart failure with reduced ejection fraction, and improve clinical decision making using guideline-directed medical therapy, including the angiotensin receptor–neprilysin inhibitors. This activity is based on the 2016 ACC.16 Heart Failure Clinical Focus Session and the 2016 American College of Cardiology/American Heart Association/Heart Failure Society of America Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. This case is based on the ACC.16 Clinical Focus Session: The Nuts and Bolts of Heart Failure Therapies: Pharmacological Case Challenges.

Treating Hyperlipidemia in Patients with Diabetes
Jul 15, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in treating hyperlipidemia in patients with diabetes. This case is based on the ACC.16 Clinical Focus Session: Dyslipidemia Combo-Therapy: A Framework for Clinical Decision-making.

Treating Hyperlipidemia in Patients at Increased Risk of ASCVD
Jul 13, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence and performance in treating hyperlipidemia with or without combination therapy. This case is based on the ACC.16 Clinical Focus Session: Dyslipidemia Combo-Therapy: A Framework for Clinical Decision-making.

MORE

Preventing and Experiencing Ischemic Heart Disease as a Woman
Jul 06, 2016 | CME 0.5 CE 0.5 COP 0.5

The overall goal of this activity is to familiarize you with Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association (AHA), and to change your competence in treating women with ischemic heart disease (IHD).

Management of Anticoagulation Agents in Elderly Patients with Atrial Fibrillation
Jun 28, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in managing elderly patients with atrial fibrillation (AF), and patient outcomes. This case is based on the ACC.16 Clinical Focus Session: The Future of Bleeding Management: Is Your Team Ready?

Novel Oral Anticoagulation Use
Jun 27, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in managing patients who require novel oral anticoagulants. This case is based on the ACC.16 Clinical Focus Session: The Future of Bleeding Management: Is Your Team Ready?

Successful Chronic Total Occlusion Percutaneous Coronary Intervention
Jun 21, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in treating patients with stable coronary artery disease and coronary artery chronic total occlusions.

Acute Myocardial Infarction in Women
Jun 16, 2016 | CME 0.5 CE 0.5 COP 0.5

The overall goal of this activity is to change your competence in managing women with acute myocardial infarction (AMI). This activity is based on the American Heart Association Scientific Statement on acute myocardial infarction in Women.

MORE

Patient with Complex Congenital Heart Disease Presents with Heart Failure
May 25, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is improve competence in evaluating congenital heart disease (CHD) patients with heart failure (HF), and improve outcomes in CHD HF patients by applying the knowledge gained.

Guideline Education: Use of Ivabradine in Heart Failure Patients
May 20, 2016 | CME 0.5 CE 0.5 COP 0.5

The overall goal of this CME certified, online activity is to familiarize you with ivabradine, including its clinical indication, starting dose, titration schedule, and potential drug interactions, and to change your competence in treating patients with heart failure.

Acute and Recurrent Venous Thromboembolism
May 10, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the 2015 CHEST Guideline for Antithrombotic Therapy for venous thromboembolism (VTE) Disease.

Aortic Dilation in Patients with Bicuspid Aortic Valves
May 03, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to update your understanding of treatment options for ascending aortic dilation in patients with bicuspid aortic valves.

Guideline Education: Pre-Excitation in Asymptomatic Patients
Apr 30, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to to review the 2015 guidelines on managing asymptomatic pre-excitation for the learner. This content is based on the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia.

MORE

Patient Presents with Crushing Chest Pain
Apr 26, 2016 | CME 0.25 COP 0.25

This CME certified online activity was planned with a goal to familiarize the learner with the 2015 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACC/AHA/SCAI) Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 American College of Cardiology Foundation (ACCF)/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction in regard to non-culprit PCI.

An Evidence-Based Approach to Treatment of Acute Pulmonary Embolism
Apr 12, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to provide an evidence-based approach for diagnosing, managing, and treating patients with acute pulmonary embolism through a case presentation.

Diagnosis and Management of Acute and Recurrent Pericarditis
Mar 01, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the 2015 European Society of Cardiology guidelines for the diagnosis and management of pericardial diseases as they relate to acute pericarditis.

Novel Heart Failure Medication for Use in Treating Patients with HFrEF
Feb 25, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize you with the newly approved, novel HF medication sacubitril-valsartan and to change your competence in treating patients with HFrEF.

Guideline Education: Patient Presents with Anterior STEMI
Feb 10, 2016 | CME 0.25 COP 0.25

This CME certified online activity was planned with a goal of familiarizing the learner with the 2015 update to the Guideline on Percutaneous Coronary Intervention and the Management and Treatment of ST-Segment Elevation Myocardial Infarction regarding the use of thrombectomy during acute myocardial infarction.

21-Year-Old Patient Presents with 4-Day History of Chest Pain
Feb 08, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in identifying and treating patients with acute myopericarditis.

MORE

Guideline Education: Narrow QRS Complex Tachycardia
Feb 03, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia.

Patient with Ischemic Cardiomyopathy Presents with Symptomatic Mitral Regurgitation
Feb 01, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to change your competence in recognizing the role for percutaneous mitral valve repair in patients with ischemic cardiomyopathy and degenerative mitral regurgitation (MR).

Incidental Murmur on Screening Physical Exam
Jan 21, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to familiarize the learner with the 2015 updates to the 36th Bethesda Conference on the eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities. This activity is based on the Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.

Guideline Education: Patient Presents with a Newly Diagnosed Heart Murmur
Jan 19, 2016 | CME 0.25 COP 0.25

The goal of this CME certified, online activity is to recognize the role of ancillary testing when evaluating a patient with severe aortic stenosis. This content is based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.

Right-sided Infective Endocarditis
Jan 13, 2016 | CME 0.25 COP 0.25

The overall goal of this CME certified, online activity is to improve your competence in recognizing and treating right-sided infective endocarditis. This activity is based on the 2015 American Heart Association (AHA) Infective Endocarditis in Adults scientific statement.

  JACC Journals CME/MOC
  JACC Journals CME/MOC

Cellular Substrate of Post-MI VT ( JACC: Clinical Electrophysiology July 2017)
July 17, 2017 | CME 1 MOC 1 COP 1

The critical isthmus (CI) in post-MI re-entrant VT is a target for catheter ablation. In vitro evidence suggests that myofibroblasts (MFB) within the scar border zone (BZ) may increase the susceptibility to slow conduction and VT but whether this occurs in vivo remains unproven.

Palliative Care in Heart Failure (JACC July 2017)
July 10, 2017 | CME 1 MOC 1 COP 1

Advanced heart failure (HF) is characterized by high morbidity and mortality. Conventional therapy may not sufficiently reduce patient suffering and maximize quality of life.

Integrating CT Myocardial Perfusion and CT-FFR in the Work-Up of Coronary Artery Disease (JACC: Cardiovascular Imaging July 2017)
July 3, 2017 | CME 1 MOC 1 COP 1

Coronary CT angiography (CTA) has become an established diagnostic test for ruling out CAD, but does not allow for interpretation of the hemodynamic severity of stenotic lesions. Two recently introduced functional CT techniques are dynamic myocardial perfusion imaging and CTA-FFR using computational fluid dynamics.

Stenting or Surgery for Common Femoral Artery (JACC: Cardiovascular Interventions July 2017)
July 3, 2017 | CME 1 MOC 1 COP 1

The aim of this study was to describe the safety and outcome of alcohol septal ablation (ASA) in younger patients with obstructive hypertrophic cardiomyopathy (HCM).

Angiotensin receptor neprilysin inhibition in HFpEF (JACC: Heart Failure July 2017)
June 26, 2017 | CME 1 MOC 1 COP 1

The Prospective comparison of ARni with ARB Global Outcomes in HF with preserved ejectioN fraction (PARAGON-HF) trial is designed to determine the efficacy and safety of the angiotensin receptor neprilysin inhibitor sacubitril/valsartan compared with valsartan in patients with chronic heart failure and preserved ejection fraction (HFpEF).

First-time Myocardial Infarction and Antithrombotics in patients with Atrial Fibrillation (JACC June 2017)
June 12, 2017 | CME 1 MOC 1 COP 1

Patients with atrial fibrillation (AF) have an increased risk of thromboembolic events such as stroke and myocardial infarction (MI). While superior efficacy of anticoagulation over antiplatelets has been established for stroke prophylaxis in AF, the optimal antithrombotic treatment remains uncertain for the primary protection of MI.

Subclinical Myocardial Impairment in Metabolic Diseases (JACC: Cardiovascular Imaging June 2017)
June 5, 2017 | CME 1 MOC 1 COP 1

Type 2 diabetes mellitus (T2DM) and obesity are important contributors to non-ischemic heart failure (HF) and atrial fibrillation (AF). There is a 2- to 5-fold increase in HF associated with T2DM, and there is a 5% in HF risk in men and 7% increment in women for every unit increment in BMI, after adjustment for traditional cardiovascular risk factors. Likewise, the risk of AF increases by about 6% per unit increase in BMI. Metabolic cardiomyopathy leads to a number of changes in cardiac structure and function that can be recognized by imaging in the asymptomatic phase, and these parameters can be used for monitoring the progression of disease or the response to therapy. The purpose of this review is to familiarize clinicians with the potential benefits of early detection of preclinical myocardial abnormalities, as well as the mechanisms that might inform interventions to prevent disease progression in patients with T2DM and obesity.

Age Specific Outcomes of ASA for HOCM (JACC: Cardiovascular Interventions June 2017)
June 5, 2017 | CME 1 MOC 1 COP 1

The aim of this study was to describe the safety and outcome of alcohol septal ablation (ASA) in younger patients with obstructive hypertrophic cardiomyopathy (HCM).

A New Clinically Applicable Measure of Functional Status in Patients with Heart Failure: The 60-Foot Walk Test (JACC: Heart Failure June 2017)
May 29, 2017 | CME 1 MOC 1 COP 1

We report the development and predictive value of the 60-foot walk test (60ftWT), a brief functional status measure for heart failure (HF) patients. The goal was to develop a test suitable for clinical settings and appropriate for patients with walking impairments.

Molecular and cellular mechanisms of fibrosis in AF (JACC: Clinical Electrophysiology)
May 15, 2017 | CME 1 MOC 1 COP 1

This ACC JACC Journals CME/MOC activity includes the reading of an article published in one of the JACC journals and the successful completion of self-assessment questions.

MORE

Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment (JACC)
May 08, 2017 | CME 1 MOC 1 COP 1

Using cardiovascular disease (CVD) risk instead of, or in addition to, blood pressure (BP) to guide antihypertensive treatment is an active area of research. The purpose of this review is to provide an overview of studies that may inform this treatment paradigm.

Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC (JACC: Cardiovascular Imaging)
May 01, 2017 | CME 1 MOC 1 COP 1

AEs are frequent in patients with ARVC but risk stratification in subjects with early ARVC is challenging.

Contemporary Incidence, Management and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions (JACC: Cardiovascular Interventions)
May 01, 2017 | CME 1 MOC 1 COP 1

The contemporary prevalence and management of coronary chronic total occlusions (CTOs) is understudied.

Ticagrelor Removal (JACC: Basic to Translational Science)
Apr 24, 2017 | CME 1 MOC 1 COP 1

This ACC JACC Journals CME/MOC activity includes the reading of an article published in one of the JACC journals and the successful completion of self-assessment questions.

Acute Heart Failure: Alternatives to Hospitalization (JACC: Heart Failure)
Apr 24, 2017 | CME 1 MOC 1 COP 1

Acute heart failure (HF) is a major public health problem with substantial associated economic costs. Since most patients who present to hospitals are admitted irrespective of their level of risk, novel approaches to manage acute HF are needed, such as the use of same-day access clinics for outpatient diuresis and observation units from the emergency department (ED). Current literature lacks a comprehensive overview of the present state of acute HF management in various clinical settings. In this review, we summarize the strengths and limitations of acute HF care in the outpatient and ED settings. Finally, we discuss a variety of innovative technologies that have the potential to improve acute HF management.

MORE

ICD remote monitoring systems specificities (JACC: Clinical Electrophysiology)
Apr 18, 2017 | CME 1 MOC 1 COP 1

This ACC JACC Journals CME/MOC activity includes the reading of an article published in one of the JACC journals and the successful completion of self-assessment questions.

Estimating Left Ventricular Filling Pressure by Echocardiography (JACC)
Apr 10, 2017 | CME 1 MOC 1 COP 1

The diagnosis of heart failure may be challenging since symptoms are rather nonspecific. Elevated LV filling pressure may be used to confirm the diagnosis, but cardiac catheterization is often not practical. Echocardiographic indices are therefore used as markers of filling pressure. This study investigated the feasibility and accuracy of comprehensive echocardiography in identifying patients with elevated LV filling pressure.

Strain in Light Chain Amyloid Heart Disease (JACC: Cardiovascular Imaging)
Apr 03, 2017 | CME 1 MOC 1 COP 1

Cardiac amyloidosis (CA) is the major determinant of outcome in AL amyloidosis. The current prognostic staging system is based primarily on serum levels of cardiac troponin T (cTnT), N-terminal fragment of brain natriuretic peptide (NT-proBNP), and free-light chain differential (FLC-diff).

Comparative Efficacy of Endovascular Revascularization vs. Supervised Exercise Training in Patients with Intermittent Claudication: Meta-analysis of Randomized Controlled Trials (JACC: Cardiovascular Interventions)
Apr 03, 2017 | CME 1 MOC 1 COP 1

Guidelines recommend supervised exercise training (SET) as initial treatment modality for patients with intermittent claudication (IC). The role of endovascular revascularization (ER) as primary treatment has been controversial.

Interaction Between Spironolactone and Natriuretic Peptides in Patients With HF and Preserved EF: From The TOPCAT Trial (JACC: Heart Failure)
Mar 27, 2017 | CME 1 MOC 1 COP 1

Plasma natriuretic peptides (NP) are helpful in the diagnosis of heart failure (HF) with preserved ejection fraction (HFpEF) and elevated levels are associated with adverse outcomes. Levels of NP above a certain cut-off are often used as inclusion criteria in clinical trials of HFpEF to confirm that patients have HF and are at higher risk. Whether treatments have a differential effect on outcomes across levels of NP levels is unclear.

MORE

Inappropriate Sinus Tachycardia Ablation. Systematic Review of the Literature (JACC: Clinical Electrophysiology)
Mar 20, 2017 | CME 1 MOC 1 COP 1

Sinus node (SN) ablation/modification has been proposed for patients refractory to pharmacologic therapy. However, available data derives from limited series.

LV Diastolic Function-E/A and E/e' (JACC)
Mar 13, 2017 | CME 1 MOC 1 COP 1

Diastolic dysfunction represents a combination of impaired left ventricular relaxation, restoration forces, myocyte lengthening load, and atrial function culminating in elevated left ventricular filling pressures. Current Doppler echocardiography guidelines recommend the use of E/A to assess diastolic function and E/e' to estimate left ventricular filling pressures. While both parameters have important diagnostic and prognostic implications, their interpretation in the individual patient should be taken in context of a patient's age and the rest of the echocardiogram to describe diastolic function and guide patient management. In this review, we discuss (1) the physiological basis for the E/A and E/e' ratios; (2) the role of these parameters in diagnosing diastolic dysfunction; (3) prognostic implications of abnormalities in E/A and E/e'; (4) special scenarios of the E/A and E/e' ratios that are either useful or challenging when evaluating diastolic function clinically; and (5) the utility of these indices in guiding therapeutic decision-making.

The Quantitative Science of Evaluating Imaging Evidence: A Review (JACC: Cardiovascular Imaging)
Mar 06, 2017 | CME 1 MOC 1 COP 1

Cardiovascular diagnostic imaging tests are increasingly used in everyday clinical practice, but are often imperfect, just like any other diagnostic test. The performance of a cardiovascular diagnostic imaging test is usually expressed in terms of sensitivity and specificity compared with the reference standard (‘gold standard’) for diagnosing the disease. However, evidence-based application of a diagnostic test also requires knowledge about the pre-test probability of disease, the benefit of making a correct diagnosis, the harm caused by false-positive imaging test results, and potential adverse effects of performing the test itself. To assist in clinical decision making regarding appropriate use of cardiovascular diagnostic imaging tests, we reviewed quantitative concepts related to diagnostic performance (e.g., sensitivity, specificity, predictive values, likelihood ratios), as well as possible biases and solutions in diagnostic performance studies, Bayesian principles, and the threshold approach to decision making.

The Role of Post-Resuscitation Electrocardiogram in Patients with ST-Segment Changes in Immediate Post-Cardiac Arrest Period (JACC: Cardiovascular Interventions)
Mar 06, 2017 | CME 1 MOC 1 COP 1

We aimed to evaluate the role of post-resuscitation electrocardiogram (ECG) in patients showing significant ST-segment changes on initial ECG and to provide useful diagnostic indicators for physicians to determine in which out-of-hospital cardiac arrest (OHCA) patients brain computed tomography (CT) should be performed before emergency coronary angiography.

Can Vaccinations Improve Heart Failure Outcomes? Contemporary Data and Future Directions (JACC: Heart Failure)
Feb 27, 2017 | CME 1 MOC 1 COP 1

Heart failure (HF) is a chronic syndrome characterized by acute exacerbations. There is significant overlap between respiratory infections and exacerbation of underlying HF. Vaccination against respiratory infections in HF patients could serve as a potential cost-effective intervention to improve patients' quality of life and clinical outcomes. The benefits of influenza vaccination in secondary prevention of ischemic heart disease have been previously studied. However, the evidence for influenza and pneumococcal vaccination specifically in the HF population is less well established. Furthermore, questions around the optimal timing, dose, frequency, and implementation strategies are largely unanswered. This review highlights the current evidence for vaccination against influenza and pneumococcal pneumonia in HF and cardiovascular disease in general. It summarizes current understanding of the pathophysiologic mechanisms in which vaccination may provide cardioprotection. Finally, it offers opportunities for further investigation of the effects of vaccination in the HF population, including basic science, translational research, and large clinical trials.

MORE

Exercise Training in ICD patients (JACC: Clinical Electrophysiology)
Feb 20, 2017 | CME 1 MOC 1 COP 1

Implantable cardioverter defibrillators (ICDs) have been shown to improve survival in patients with heart failure (HF). However, many patients with ICDs experience fear of shocks and avoid physical activity. Little data exist on efficacy and safety of exercise training in HF patients with ICDs.

Advances in the Genetics of Congenital Heart Disease: A Clinician's Guide (JACC)
Feb 13, 2017 | CME 1 MOC 1 COP 1

Our understanding of the genetics of congenital heart disease (CHD) is rapidly expanding. However, many questions, particularly those relating to sporadic forms of disease, remain unanswered. Massively parallel sequencing technology has made significant contributions to the field, both from a diagnostic perspective for patients, but, importantly, also from the perspective of disease mechanism.

Value of CAC Above Statin Guidelines in Primary Prevention (JACC: Cardiovascular Imaging)
Feb 06, 2017 | CME 1 MOC 1 COP 1

The aim of this study was to assess the difference in indication for statin therapy by European Society of Cardiology (ESC) versus American Heart Association/American College of Cardiology (AHA/ACC) guidelines and to quantify the potential additional role of coronary artery calcification (CAC) score over updated guidelines in a primary prevention cohort.

Carotid Revascularization and Coronary Artery Bypass Graft Surgery (JACC: Cardiovascular Interventions)
Feb 06, 2017 | CME 1 MOC 1 COP 1

The aim of this study was to compare trends and outcomes of 3 approaches to carotid revascularization in the CABG population when performed during the same hospitalization.

The Affordable Care Act Medicaid Expansion Correlated With Increased Heart Transplant Listings In African-Americans But Not Hispanics Or Caucasians (JACC: Heart Failure)
Jan 30, 2017 | CME 1 MOC 1 COP 1

The aim of this study was to determine if the Affordable Care Act (ACA) Medicaid Expansion was associated with increased census-adjusted heart transplant listing rates for racial/ethnic minorities.

MORE

CIED infections in patients with abandoned leads (JACC: Clinical Electrophysiology)
Jan 16, 2017 | CME 1 MOC 1 COP 1

The population of patients with cardiac implantable electronic devices continues to grow with a disproportionate increase in device infections, which are invariably life threatening. A potentially complicating issue is the widely practiced strategy of device lead abandonment at the time of system revision, change, or upgrade, which is affecting an increasing number of patients.

Quantitative Evaluation of Imaging Evidence (JACC: Cardiovascular Imaging March 2017)
Jan 9, 2017 | CME 1 MOC 1 COP 1

Cardiovascular diagnostic imaging tests are increasingly used in everyday clinical practice, but are often imperfect, just like any other diagnostic test. The performance of a cardiovascular diagnostic imaging test is usually expressed in terms of sensitivity and specificity compared with the reference standard (‘gold standard’) for diagnosing the disease. However, evidence-based application of a diagnostic test also requires knowledge about the pre-test probability of disease, the benefit of making a correct diagnosis, the harm caused by false-positive imaging test results, and potential adverse effects of performing the test itself. To assist in clinical decision making regarding appropriate use of cardiovascular diagnostic imaging tests, we reviewed quantitative concepts related to diagnostic performance (e.g., sensitivity, specificity, predictive values, likelihood ratios), as well as possible biases and solutions in diagnostic performance studies, Bayesian principles, and the threshold approach to decision making.

Cardiac Pacing: Part II (JACC)
Jan 09, 2017 | CME 1 MOC 1 COP 1

In the second part of this two-part series on pacemakers, we present recent advances in pacemakers and preview future developments. Cardiac resynchronization therapy is a potent treatment for heart failure in the setting of ventricular dyssynchrony.

Left Atrial Reverse Remodeling (JACC: Cardiovascular Imaging)
Jan 02, 2017 | CME 1 MOC 1 COP 1

The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial (LA) enlargement is of prognostic importance. LA enlargement with a consequent decrease in LA function, represents maladaptive structural and functional ‘remodeling’, that in turn promotes electrical remodeling and a milieu conducive for incident atrial fibrillation. Medical and non-medical interventions may arrest this pathophysiologic process to the extent that subsequent reverse remodeling results in a reduction in LA size and improvement in LA function. This review will examine cellular and basic mechanisms that are involved in LA remodeling, evaluate the non-invasive techniques that can assess these changes and examine potential mechanisms that may initiate reverse remodeling.

Clinical Outcomes of Pedal Artery Angioplasty for Patients with Ischemic Wounds; Results from the Multicenter RENDEZVOUS Registry (JACC: Cardiovascular Interventions)
Jan 02, 2017 | CME 1 MOC 1 COP 1

To investigate the clinical outcomes of pedal artery angioplasty (PAA) for patients with critical limbs ischemia (CLI).

MORE

Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes - Findings from ASCEND-HF (JACC: Heart Failure)
Dec 26, 2016 | CME 1 MOC 1 COP 1

Body weight changes during and after hospitalization for acute heart failure (AHF) and the relationships with outcomes have not been well-characterized.

Optimal, Endocardial LV Delivered CRT (JACC: Clinical Electrophysiology)
Dec 19, 2016 | CME 1 MOC 1 COP 1

LV endocardial pacing may offer benefit over conventional CRT ischemic patients.

Prosthetic Heart Valve Thrombosis (JACC)
Dec 12, 2016 | CME 1 MOC 1 COP 1

Although surgery was the mainstay of treatment for valvular heart disease, transcatheter valve therapies have grown exponentially over the past decade. Two types of artificial heart valve exist: mechanical heart valves (MHV), which are implanted surgically, and bioprosthetic heart valves (BHV), which can be implanted via a surgical or transcatheter approach.

Blood Pressure and Left Ventricular Remodeling Among American Style Football Players (JACC: Cardiovascular Imaging)
Dec 05, 2016 | CME 1 MOC 1 COP 1

Participation in ASF has been associated with the development of hypertension and LV hypertrophy. To what degree these processes impact LV function is unknown.

Importance of Both Early Reperfusion and Therapeutic Hypothermia in Limiting Myocardial Infarct Size Post Cardiac Arrest in a Porcine Model (JACC: Cardiovascular Interventions)
Dec 05, 2016 | CME 1 CNE 1 MOC 1

The aim of this study was to test the hypothesis that hypothermia and early reperfusion are synergistic for limiting infarct size when an acutely occluded coronary is associated with cardiac arrest.

MORE

Association of 30-day Readmission Metric for Heart Failure under the Hospital Readmissions Reduction Program with Quality of Care and Outcomes (JACC: Heart Failure)
Nov 28, 2016 | CME 1 MOC 1 COP 1

To determine whether processes of care and long-term clinical outcomes for heart failure (HF) admissions across GWTG-HF participating centers differ according to HF-specific risk-adjusted 30-day readmission rates (excess readmission ratio, ERR) as determined by the Hospital Readmission Reduction Program (HRRP).

CF Stability Determines Successful PV Isolation (JACC: Clinical Electrophysiology)
Nov 21, 2016 | CME 1 MOC 1 COP 1

Pulmonary vein reconnection remains a major cause of AF recurrence following catheter ablation. Durable ablation lesions could minimize such recurrence.

Vicious Twins - Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation (JACC)
Nov 14, 2016 | CME 1 MOC 1 COP 1

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are age-related conditions that are increasing in prevalence, commonly co-exist and share clinical features. This review provides a practical update on the epidemiology, pathophysiology, diagnosis and management of patients with concomitant HFpEF and AF.

Long Term Prognostic Utility of Coronary CT Angiography in Stable Patients with Diabetes Mellitus (JACC: Cardiovascular Imaging)
Nov 04, 2016 | CME 1 MOC 1 COP 1

The long-term prognostic value of CTA in diabetics is not well established.

Permanent Pacemaker Outcomes after TAVR (JACC: Cardiovascular Interventions)
Nov 04, 2016 | CME 1 MOC 1 COP 1

The purpose of this study was to evaluate the incidence, predictors and clinical outcomes of PPM placement following TAVR.

MORE

Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis (JACC: Heart Failure)
Oct 31, 2016 | CME 1 MOC 1 COP 1

Atrial fibrillation (AF) is quite prevalent in patients with heart failure (HF).

Time Dependence of Ventricular Tachyarrhythmias after Myocardial (JACC: Clinical Electrophysiology)
Oct 17, 2016 | CME 1 MOC 1 COP 1

Patients with left ventricular dysfunction after myocardial infarction (MI) are at high risk for ventricular tachyarrhythmic events (VTEs).

Risk Decisions in Lower-Risk People (JACC)
Oct 10, 2016 | CME 1 MOC 1 COP 1

Guidelines from the American College of Cardiology/American Heart Association, as well as from the VA-Department of Defense and the Joint British Societies all recommended treating more people with statins than previous guidelines. In each guideline, the decision-making process begins with an assessment of overall cardiovascular risk. Updated treatment thresholds were proposed by each group, and all of them lowered the threshold compared to earlier guidelines. Since release of these new guidelines in 2013 and 2014, additional evidence has emerged to suggest a rationale for extending statin consideration to an even larger proportion of asymptomatic adults - even below 7.5% atherosclerotic cardiovascular disease risk in 10 years. This review discusses new findings since 2013 and proposes strategies emanating from the current guidelines to help clinicians and patients make more informed decisions about long-term statin use, especially pertinent to lower risk individuals.

A Bicuspid Aortic Valve Imaging Classification for the Transcatheter Aortic Valve Implantation Era (JACC: Cardiovascular Imaging)
Oct 03, 2016 | CME 1 MOC 1 COP 1

TAVI has been used to treat BAV-AS but with heterogeneous outcomes and uncertainty regarding the relevance of morphology.

Prevention of Radial Artery Occlusion After Transradial Catheterization: The PROPhylactic Hyperperfusion Evaluation Trial (PROPHET-II) Randomized Trial (JACC: Cardiovascular Interventions)
Oct 03, 2016 | CME 1 MOC 1 COP 1

Radial artery occlusion (RAO) after transradial access (TRA) is a structural complication of TRA. It limits future ipsilateral TRA and may cause transient pain. Maintaining radial artery flow during hemostasis reduces the incidence of acute RAO. Ipsilateral ulnar compression increases radial artery flow and could impact the incidence of RAO.

MORE

The Impact of Obesity on Patients Bridged to Transplantation with Continuous-Flow Left Ventricular Assist Devices (JACC: Heart Failure)
Sep 26, 2016 | CME 1 MOC 1 COP 1

This study sought to determine if obese patients had worse post-LVAD implantation outcomes and if the implantation of an LVAD allowed for weight loss.

AL (Light-Chain) Cardiac Amyloidosis (JACC)
Sep 12, 2016 | CME 1 MOC 1 COP 1

The amyloidoses are a group of protein folding disorders in which one or more organs are infiltrated by proteinaceous deposits known as amyloid. The deposits are derived from one of several amyloidogenic precursor proteins and the prognosis of the disease is determined both by the organ(s) involved and the type of amyloid. Amyloid involvement of the heart (cardiac amyloidosis) carries the worst prognosis of any involved organ, and light chain (AL) amyloidosis is the most serious form of the disease. The last decade has seen considerable progress in understanding the amyloidoses and, this review, we discuss current and novel approaches to the diagnosis and treatment of cardiac amyloidosis, with particular reference to AL amyloidosis in the heart.

Chronic Total Occlusion in Heart Failure (JACC: Cardiovascular Interventions)
Sep 05, 2016 | CME 1 MOC 1 COP 1

This study sought to assess the impact of the CTO on long-term prognosis in patients with ischemic cardiomyopathy.

CTA for Detection of CAD Before Valve Surgery (JACC: Cardiovascular Imaging)
Sep 01, 2016 | CME 1 MOC 1 COP 1

Coronary CTA is currently not routinely recommended for detecting coronary artery stenoses before cardiac valve surgery. However, recent improvements in CT technology may enable the identification of the most appropriate candidates for coronary CTA prior to valve surgery.

ATHENA HF Trial (JACC: Heart Failure)
Aug 29, 2016 | CME 1 MOC 1 COP 1

While therapy with mineralocorticoid receptor antagonists (MRA) is recommended for patients with chronic heart failure (HF) with reduced ejection fraction and in post-infarction HF, it has not been studied well in acute HF (AHF) despite being commonly used in this setting.

  Meeting On Demand Programs
  Meeting On Demand Programs

ACC.17 Clinical Focus Session: The Great K Debate Continues: Updates and Controversies in Heart Failure Management
June 26, 2017 | MOC 2.0 CNE 2.0 CME 2.0 COP 2.0

With updated Heart Failure guidelines, new drugs and side-effect management concerns, the Great K Debate continues with this Meeting on Meeting on Demand™ Program. Join us for this highly interactive session carefully planned to help providers understand how to overcome the challenge of patient side-effect concerns, particularly hyperkalemia, while allowing for the optimization HF pharmacotherapies, including a look at the new drugs for treating hyperkalemia and management strategies for their administration.

ACC.17 Clinical Focus Session: Complex Decisions in Mitral Valve Care: Individualizing Assessment, Diagnosis and Treatment
June 26, 2017 | MOC 2.0 CNE 2.0 CME 2.0 COP 2.0

During this Meeting on Demand™ Program, Complex Decisions in Mitral Valve Care: Individualizing Assessment, Diagnosis and Treatment, learners will gain a better understanding of the current barriers and complexities of mitral valve care, learn best practices and strategies and see the guidelines in practice during challenging case presentations and discuss recent advances and the future of valve care with an expert faculty panel.

ACC.17 Clinical Focus Session: Recent Trends in Combination Therapy: Managing Cholesterol Even in the Most Resistant
June 26, 2017 | MOC 2.0 CNE 2.0 CME 2.0 COP 2.0

Managing cholesterol levels effectively, particularly in the most resistant patients, can be a challenge. Recent trends call for incorporating evidence-based nonstatin therapies into treatment plans, yet providers and patients seem to struggle with this combination therapy approach. This interactive session reviews how clinicians are doing in the treatment of high-risk patients and why they might be struggling with prescribing evidence based therapies. The patient’s perspectives and patient related adherence issues or barriers are included also in the discussion followed by the systems of care stumbling blocks. Review, analyze and view discussions on how to build a friendlier system of care for clinicians and patients.

ACC.17 Clinical Focus Session: Next Steps to Optimal Medical Therapy for Heart Failure Patients
June 26, 2017 | MOC 2.0 CNE 2.0 CME 2.0 COP 2.0

Heart failure represents a significant source of morbidity and mortality in the US population and worldwide. It is estimated that the number of persons with heart failure in the U.S. will soon approach 8 million and the toll on life and quality of life will continue to rise. In 2015, the US Food and Drug Agency (FDA) approved two HF medications—the first new pharmacologic therapies for HF in more than a decade. We now have a plethora of drugs and devices appropriate for heart failure and the complexity of care has increased. After two years now of clinical use of the newest agents and coupled with the recent release of updated guidelines, clinicians have questions and need practical guidance on the new pharmacotherapies and how they should be incorporated into individualized treatment regimens with consideration for ethnic/racial and other clinically relevant attributes of patients with HF. Education on the role of guideline-driven MT,(GDMT), including appropriate use of both newer and more familiar medications, is a crucial tool in achieving desired chronic HF outcomes, including reduced hospitalization and readmission rates as well as overall reduced morbidity and mortality.

ACC.17 Clinical Focus Session: Breakthrough Therapies: Your Role in Protecting the Heart of Your Patient with Diabetes
June 26, 2017 | MOC 2.0 CNE 2.0 CME 2.0 COP 2.0

Whether heart disease or diabetes came first, caring for patients with these conditions is complex and places demands on cardiovascular clinicians to stay up-to-date on new findings and pharmaceutical agents and how they may affect or alter care of their patients. This dynamic, interactive session will feature a review of glycemic management and cardiovascular disease, an evaluation of the latest findings of cardiotoxic and cardio-protective profiles of pharmacological diabetes agents and their effectiveness in preventing ASCVD in diabetes. The activity closed with some pragmatic conversations about the cardiovascular clinician’s role and responsibility in caring for the patient with diabetes. With the growing number of T2DM patients in the population, all cardiovascular providers should find this evening session useful and informative.

Insights on Access Barriers and Overcoming Administrative Burdens for New Therapies
Mar 22, 2017

Prior authorization and claim denials continue to be some of the top challenges facing physicians. According to a 2012 Kaiser Family Foundation study, U.S. physicians spend more than 868 million hours annually on prior authorization activities—a trend that is only likely to continue.

In October 2016, CardioSurve participants were asked questions related to access and usage of new cardiovascular drug therapies. This research was designed to develop a general understanding from U.S. cardiologists of their perceptions of access to new therapies and usage for their patients with a focus specifically on angiotensin receptor-neprilysin inhibitor (ARNIs), Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) and Novel Oral Anticoagulants (NOACs). The survey was sent to 405 current, active fellows of the American College of Cardiology, and 151 panelists completed the survey for an overall response rate of 37%.

Guideline Driven Heart Failure: Contemporary Perspectives and Future Considerations with a focus on China
Mar 10, 2017 | COP 1.5

This enlightening Meeting on Demand discusses the medical management of heart failure with a particular focus on China. Current treatment considerations and perspectives are covered, along with a discussion surrounding caring for heart failure patients in the future. The videos were recorded at the Great Wall International Congress of Cardiology in Beijing, China on October 15, 2016. The session was chaired by Zhang Jian, MD, FACC and Lee Goldberg, MD, FACC and featured JoAnn Lindenfeld, MD, FACC, and Tong Liu, MD as speakers. We have included links to the Guideline, the Focused Update, an extensive Heart Failure Workbook, and Patient Education materials. After completing the brief post-test associated with these materials, you will receive a certificate of completion from the American College of Cardiology (ACC). ACC would like to thank Novartis for sponsoring the ACC Global Heart Failure Series through an educational grant.

Guideline Driven Heart Failure: Contemporary Perspectives and Future Considerations with a focus on Mexico
Dec 08, 2016

This enlightening Meeting on Demand discusses the medical and surgical treatment and management of heart failure with a particular focus on Mexico. Current treatment considerations and perspectives are covered, along with a discussion surrounding caring for heart failure patients in the future. The videos were recorded at the World Congress of Cardiology in Mexico City, Mexico on June 5, 2016. The session was chaired by President of the Mexican Society of Cardiology Erick Alexanderson, MD, FACC and Robert Bonow, MD, FACC and featured Daniel Piñeiro, MD, FACC, John McMurray, MD, FACC, and Adolfo Chavez Meñdoza, MD as speakers. In addition to the session, as part of the MOD, you also have access to video from ACC.16. We have included links to the Guideline, the Focused Update, an extensive Heart Failure Workbook, and Patient Education materials. ACC would like to thank Novartis for sponsoring the ACC Global Heart Failure Series through an educational grant.

Guideline Driven Heart Failure: Contemporary Perspectives and Future Considerations with a focus on Asia Pacific
Oct 13, 2016

This enlightening Meeting on Demand discusses the medical and surgical treatment and management of heart failure with a particular focus on the Asia Pacific region. Current treatment considerations and perspectives are covered, along with a discussion surrounding caring for heart failure patients in the future. The videos were recorded at the Korea Society of Cardiology/Asia Pacific Congress on Heart Failure in Gyeongju, Korea on April 16, 2016. The session was chaired by President Elect Mary Norine Walsh, MD, FACC and Eun-Seok Jeon, MD, PhD and featured Lee Goldberg, MD, MPH, FACC and Seok Min Kang, MD as speakers. In addition to the session, as part of the MOD, you also have access to video from ACC.16. We have included links to the Guideline, an extensive Heart Failure Workbook, and Patient Education materials. ACC would like to thank Novartis for sponsoring the ACC Global Heart Failure Series through an educational grant.

2016 Interventional Cardiology Overview and Board Prep Meeting on Demand Program
Sep 19, 2016

Intensive, comprehensive and informative — this Meeting on Demand Program will ensure you are prepared for the Boards and for your patients!

The Interventional Cardiology Overview and Board Preparatory Course Meeting on Demand Program combines the relevant review you need for your daily practice with proven learning techniques to help you pass your Boards. Presentations from an expert faculty plus interactive multiple-choice questions enable you to quickly identify and address your learning gaps.

Providing the most up-to-date, evidence-based review of interventional cardiology available, this educational offering’s esteemed faculty will engage you in discussions of ABIM exam guidelines that focus on the main content areas tested on the Boards:

  • Case Selection and Management
  • Pharmacology
  • Catheter-based Management of Noncoronary disease
  • Cardiac Imaging and Assessment
  • Complications of Coronary Intervention
  • Basic Science
  • Anatomy, Anatomic Variants, Anatomic Pathology

Additionally, the faculty also discusses HOT TOPICS — what you won’t see on the Boards but need to know! This year’s hot topics include CTO and TAVR.

In addition to the expert presentations listed above, this product includes:

  • Online practice exam featuring over 300 questions so you can test your knowledge.
  • Printable PDFs of all lectures.
  • Downloadable MP3s of all audio presentations.

Guideline Driven Heart Failure: Contemporary Perspectives and Future Considerations with a focus on Latin America
Sep 15, 2016

This enlightening Meeting on Demand discusses the medical and surgical treatment and management of heart failure with a particular focus on Latin America. Current treatment considerations and perspectives are covered, along with a discussion surrounding caring for heart failure patients in the future. The videos were recorded at the Chilean Society of Cardiology and Cardiac Surgery/Inter-American in Santiago, Chile on December 6th. The session was chaired by Lee Goldberg, MD, FACC and Roberto Concepcion, MD and featured Pamela Peterson, MD, FACC and Mirta Diez, MD as speakers. In addition to the sessions, as part of the MOD you also have access to a Clinical Focus Session on Heart Failure from ACC.15 in San Diego. We have included links to the Guidelines, an extensive Heart Failure Workbook, and Patient Education materials. ACC would like to thank Novartis for sponsoring the ACC Global Heart Failure Series through an educational grant.

2016 Recent Advances in Clinical Nuclear Cardiology and Cardiac CT Meeting on Demand Program
Jul 27, 2016

The 2016 Recent Advances in Clinical Nuclear Cardiology and Cardiac CT Meeting on DemandTMProgram is perfect for you if you are:

  • Interested in earning your IAC accreditation requirements of 15 Nuclear Credit Hours
  • Preparing for the Nuclear (CBNC) and/or Cardiac CT (CBCCT) Boards
  • Looking for a review of 101 evidence-based cases focusing on technical and clinical problems commonly encountered in practice to increase your interpretive skills

Designed to meet the needs of professionals who perform or request nuclear cardiology, cardiac CT or cardiac MRI studies, this online course emphasizes the use of these modalities across the spectrum of patients with suspected or known coronary disease as well as other non-coronary cardiac disease states.

Join a faculty of expert cardiac imaging clinicians and scientists from across the country who will guide you through the latest advances in nuclear cardiology, cardiac CT and other imaging modalities while you:

  • Explore the latest instrumentation/protocols to improve accuracy and reduce radiation
  • Discover the latest imaging procedures to improve patient outcomes and/or reduce costs
  • Discuss the evidence supporting value-based imaging
  Expert Analysis
  Expert Analysis

The Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk — A Dialogue With the Experts
Mar 03, 2017

This activity was planned with a goal to optimize patients on their current statin treatment strategies to achieve desired LDL reduction, and to identify patients who truly need the addition of non-statin therapies in order to reach "acceptable LDL thresholds."

Journal Club 2016
Dec 16, 2016 | CME 20 MOC 20

The continual stream of published science coupled with emphasis on practice improvement requirements has created a need for consensus building conversations that can guide practical practice change delivered at the point-of-care. However, finding the time to critically appraise the evidence or consider the practice implications has led the ACC to seek solutions not only for their members but all cardiovascular providers.

ACC’s educational program, ACC Journal Club offers opportunities to challenge emerging science, critique applicability to practice, consider practical point-of care solutions and cultivate future research opportunities that collective lead to improved cardiovascular health.

Communication Strategies for Optimizing Patient Centered Care
Sep 23, 2016 | CME 1 CE 1

The overall goal of this webinar is to improve patient care by increasing learner competence regarding communication strategies for optimizing patient centered care in older adults with cardiovascular disease at the end of life.

 
  Products
  Products
ACCEL Audio

ACCEL Audio

ACCEL, the ACC's audio journal, brings subscribers the latest information on the diagnosis and treatment of CV disease in convenient format.

Heart Songs

Heart Songs

Improve your cardiac auscultation skills! Featuring high-quality heart sounds that you can look at and listen to at your convenience using your computer or MP3 listening device.

CardioSource Plus

CardioSource Plus

CardioSource Plus is a facility-wide subscription to ACC.org. The flat fee subscription provides unlimited access to ACC’s full complement of online educational programs.

iScience 2013 MOD

iScience

iScience, the ACC.16 Meeting on Demand™ Program, provides instant access to 245 sessions, more than 1,500 presentations and cover topics in all 12 learnings pathways.

Faculty Development

ECG Drill and Practice

Improve your ECG interpretation skills with ECG Drill & Practice, a great resource for anyone preparing for initial Board certification in CV disease and for anyone looking to hone their ECG interpretation skills.

Faculty Development   Self-Assessment Programs

Refresh your knowledge of cardiovascular medicine with ACC’s Self-Assessment Programs (SAPs)! Each SAP provides a core curriculum on its topic in a comprehensive yet concise way, featuring text, presentations, images, case studies, and self-assessment questions written by the experts. They’re a great resource for staying up to date, preparing for the Boards, and/or earning CME and MOC credit.

  Self-Assessment Programs

Clinical Cardiac Electrophysiology Self-Assessment Questions and Board Prep Program
Oct 06, 2016 | CME 12.5 MOC 12.5

Are you planning to take the ABIM exam in Clinical Cardiac Electrophysiology, or just looking for a way to identify your areas of strength and weakness in the field? ACC’s new Self-Assessment Questions & Board Prep Program can help you! This product features:

  • 151 questions that allow you to assess your current level of knowledge and help you learn from a detailed commentary that accompanies each question.
  • A convenient online format that gives you feedback after you answer each question.
  • An option to print the questions in pdf format to review offline.
  • Questions written and rigorously peer reviewed by experts in the field to reflect the ABIM blueprint.

Advanced Heart Failure and Transplant Cardiology Self-Assessment Questions and Board Prep Program
Aug 03, 2016 | CME 12.5 MOC 12.5

Are you planning to take the ABIM exam in Advanced Heart Failure and Transplant Cardiology, or just looking for a way to identify your areas of strength and weakness in the field? ACC’s new Self-Assessment Questions & Board Prep Program can help you! This product features:

  • 152 questions that allow you to assess your current level of knowledge and help you learn from a detailed commentary that accompanies each question.
  • A convenient online format that gives you feedback after you answer each question.
  • An option to print the questions in pdf format to review offline.
  • Questions written and rigorously peer reviewed by experts in the field to reflect the ABIM blueprint.

ACCSAP9 Online and Print
Mar 24, 2016

Pass the Boards! Use ACCSAP 9 to prepare for the Boards:

  • Familiarize yourself with the ABIM blueprint
  • Hear expert tips on taking the exam
  • Take a simulated Board exam session & identify areas of needed study
  • Learn from educational text and lectures
  • Practice with hundreds of ABIM-style questions with rationale and references
  • Take additional simulated Board exam sessions to see your progress
  • Repeat as necessary and keep track of your progress with ACCSAP’s user-friendly dashboard

ACC's General Cardiology Module 15
Jan 04, 2016 | CME 1.5 MOC 10

Let ACC help you earn points toward the ABIM’s Maintenance of Certification program AND learn valuable information in the process! ACC’s MOC modules feature ABIM-quality questions that not only allow you to assess your current level of knowledge, but help you learn from a detailed commentary that accompanies each question explaining why the right answer is the best choice, and also why the other answer choices are suboptimal. Our convenient online format allows you to get feedback on each question as you go and submit your scores to the ABIM for MOC credit in just a few easy clicks.

Each module in our series features approximately 30 multiple-choice questions and offers 10 points toward Part II (Self-Assessment of Medical Knowledge) of the ABIM’s MOC program.

ACC’s Medical Professionalism MOC Module
Sep 18, 2015 | CME 1.5 MOC 10

ACC’s MOC modules feature ABIM-quality questions that not only allow you to assess your current level of knowledge, but help you learn from a detailed commentary that accompanies each question. Our convenient online format allows you to get feedback on each question as you go and submit your scores to the ABIM for 10 MOC points in just a few easy clicks. This module features 30 multiple-choice questions on the topic of medical professionalism, including:

  • Integrity and accountability
  • Fair and ethical stewardship of healthcare resources
  • Evaluating professionalism
  • Self-regulation
  • Commitment to excellence based on:
    • The six Core Competencies created by the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties for quality patient care with special attention to the Core Competency of Professionalism.
    • The three Fundamental Principles and Ten Commitments proposed by the American Board of Internal Medicine Foundation, the American College of Physicians, and the European Federation of Internal Medicine as developed in the Physician Charter on Medical Professionalism.

PLEASE NOTE: This module requires pop-up blockers be turned off as it will open in a separate window. If you have difficulty opening the program, please don't hesitate to contact our technical support:

Technical support for online education is available Monday-Friday, 7:00 am to 1:00 am, and Saturday-Sunday, 8:00 am to 8:00 pm (Eastern). You may contact our technical support team by email (acc@romnet.com) or call toll-free 800-461-3994, or call 617-746-2985.

Adult Congenital Heart Disease Self-Assessment Questions and Board Prep Program
Jul 09, 2015 | CME 5

Are you planning to take the ABIM exam in Adult Congenital Heart Disease, or just looking for a way to identify your areas of strength and weakness in the field? ACC’s new ACHD Self-Assessment Questions & Board Prep Program can help you! This product features:

  • More than 100 questions that allow you to assess your current level of knowledge and help you learn from a detailed commentary that accompanies each question.
  • A convenient online format that gives you feedback after you answer each question.
  • An option to print the questions in pdf format to review offline.
  • Up to 5 AMA PRA Category 1 CME Credits.
  • Questions written and rigorously peer reviewed by experts in the field to reflect the ABIM blueprint.
 
  Resources
  Resources
CME and CNE Resources

Board Prep Offerings

The ACC has a variety of MOC and board preparation resources available for you! As a leader in CV education, ACC is continuously updating and improving our educational offerings in order to keep you at the forefront of your profession. Let us help you through your MOC and Board preparation experience.

CME and CNE Resources

CME/CNE Resources

ACC is committed to ensuring that staff and volunteers involved in planning, implementing and evaluating CME/CNE activities have access to necessary resources. Find contact information for ACC staff that can provide information on CME, CNE and Joint Providership and Co-Providership.

Competencies

Competencies

The ACC has developed competencies to cover the entire career spectrum of a cardiologist, from training through practice, defining the knowledge, skills, and behaviors that physicians, patients, the public and accrediting bodies can reasonably expect clinical cardiologists in training to achieve and those in practice to maintain or enhance.

Competencies

CV Essentials Training for Industry and Other Professionals

This series of educational programs delivers clinical knowledge, disease mechanisms, and clinical treatment from the standpoint of a cardiologist while ensuring clinical consistency for both industry and health care professionals.

Faculty Development

Faculty Development

ACC has developed a resource designed to support cardiology professionals who deliver training and education in a variety of settings. If you teach medical students, present at conferences, or develop curricula, this page is for you.

Faculty Development

Fellowship Program Director Tools and Resources

Featuring content developed for Fellowship Program Directors, this section includes curriculum development resources, innovative learning tools, assessment tools, training and accreditation requirements, and tools for faculty development. Requires ACC.org login.

Guideline Education

Guideline Education

This resource collects CME, CE and/or MOC educational activities related to a variety of guidelines topics, providing physicians, nurses, and other medical professionals with a better understanding of the use of guidelines in a clinical setting.

RightSTEPS

RightSTEPS

A comprehensive curriculum to help clinicians create guideline-driven treatment plans proven to prevent the advancement of chronic HF.

Use the tabs below to find online educational activities to meet your needs! Please note that Free Activities (Patient Case Quizzes, Certified Patient Cases, JACC Journals CME/MOC, Meeting On Demand Programs and Expert Analysis) are only available to registered and logged in ACC.org users. If you haven't already registered, click here to do so now (it's free!).

Free Activities